Danish Consumer Services Stock News

Matas (CPSE:MATAS) has just posted Q3 2026 results with revenue of DKK2.8b and net income of DKK186m, translating to EPS of DKK4.95, while same store sales growth came in at 2.3%. The company has seen quarterly revenue move from DKK2.7b in Q3 2025 to DKK2.8b in Q3 2026, with EPS shifting from DKK5.30 to DKK4.95 over the same period. This sets the stage for investors to focus on how margins and profit quality shape the story behind this quarter’s print. See our full analysis for Matas. With...

Solar (CPSE:SOLAR B) FY 2025 earnings recap Solar (CPSE:SOLAR B) has just wrapped up FY 2025 with Q4 revenue of DKK 3.1b and basic EPS of DKK 13.01, while trailing twelve month revenue came in at DKK 12.2b and EPS at DKK 10.02. Over recent quarters the company has seen quarterly revenue move between DKK 2.8b and DKK 3.2b, with basic EPS ranging from a loss of DKK 3.70 in Q1 2025 to DKK 13.01 in Q4 2025. This leaves investors focused on how thin reported margins and the impact of past losses...

Djurslands Bank (CPSE:DJUR) just wrapped up FY 2025 with fourth quarter total revenue of 173.9m DKK and net income of 64.5m DKK, alongside trailing twelve month revenue of 703.0m DKK and net income of 249.8m DKK that frame the latest numbers in a broader earnings season context. Over recent periods, the bank has seen quarterly revenue move between 157.1m DKK and 198.1m DKK with net income ranging from 45.4m DKK to 83.6m DKK. Trailing twelve month net profit margin sits at 35.5% against 36.6%...

If you are wondering whether Jyske Bank’s share price still offers value after a strong run, this article will walk through what the current market price may be implying. The stock last closed at DKK 943.5, with returns of 3.7% over 7 days, 6.4% over 30 days, 7.5% year to date, 86.1% over 1 year, 85.6% over 3 years, and 308.2% over 5 years, which naturally raises questions about how much of the story is already reflected in the price. Recent attention on Jyske Bank has focused on its...

DSV (CPSE:DSV) has wrapped up FY 2025 with fourth quarter revenue of DKK 71.7b and basic EPS of DKK 4.72. Trailing 12 month revenue stands at DKK 247.3b with EPS of DKK 35.57. The company has seen quarterly revenue move from DKK 43.5b in Q4 2024 to DKK 71.7b in Q4 2025, with basic EPS shifting from DKK 9.46 to DKK 4.72 over the same period. Trailing net profit margin sits at 3.4% versus 6% a year earlier. Overall, the print points to healthy top line scale but thinner margins that keep the...

If you are wondering whether Novo Nordisk’s share price now reflects fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock last closed at DKK 280.65, with returns of 24.2% decline over 7 days, 22.9% decline over 30 days, 15.0% decline year to date, 54.5% decline over 1 year, and 38.9% decline over 3 years, while still showing a 36.1% gain over 5 years. Recent news coverage has focused heavily on Novo Nordisk’s role in diabetes and...

If you are wondering whether Vestas Wind Systems is still attractively priced after its recent run, this article will help you unpack what the current share price might be implying about future expectations. The stock trades at DKK 176.4 after a 6.1% decline over the last 7 days and a 5.8% decline over the last 30 days, although the 1 year return sits at 65.9%. These moves come as Vestas continues to be a focal point in global wind power discussions, with investors paying close attention to...

If you are wondering whether A.P. Møller - Mærsk is still fairly priced after a strong run, this article will walk you through how its current market value stacks up against several valuation checks. The stock last closed at DKK 15,385, and while the 7 day and 30 day returns both show a 1.6% decline, the shares sit on a 4.7% year to date return and 46.2% over the past year, with a 130.3% return over five years suggesting the market has reassessed the company over time. Recent news around...

Dampskibsselskabet Norden (CPSE:DNORD) has wrapped up FY 2025 with Q4 revenue of US$827.6 million and EPS of US$0.33. This capped a year where quarterly revenue moved from US$799.0 million in Q1 to US$780.2 million in Q2 and US$737.0 million in Q3, alongside EPS of US$1.10, US$1.80 and US$0.90 respectively. Over the trailing twelve months to Q4 2025, the company booked US$3.1 billion in revenue and EPS of US$4.10. Together, these figures frame a year where investors are likely to focus on how...

Danske Bank (CPSE:DANSKE) has completed its money laundering settlement, with part of the fine now earmarked by Estonia to fund new anti corruption legislation and enforcement. Authorities in Estonia are using these funds to strengthen oversight and compliance frameworks for the financial sector. Separately, Danske Bank’s asset management arm has passed DKK 1 trillion in assets under management for the first time. For you as an investor, these developments sit at the intersection of...

Shareholders might have noticed that Embla Medical hf. ( CPH:EMBLA ) filed its full-year result this time last week...

Why Netcompany Group Is On Investors’ Radar Today Netcompany Group (CPSE:NETC) is drawing fresh attention after recent share price moves, with the stock showing a 14% decline over the past month but a positive total return over the past year. That mix of short term weakness and longer term gains is prompting some investors to reassess how the company’s current DKK 318 share price lines up with its fundamentals, including revenue of DKK 7,891.7 and net income of DKK 256.9. See our latest...

FLSmidth (CPSE:FLS) is in focus after appointing Toni Laaksonen as CEO with immediate effect and continuing a share buy-back programme of up to DKK 1.4b, together reshaping the company’s leadership and capital structure. See our latest analysis for FLSmidth. At a share price of DKK571.0, FLSmidth has recently shown building momentum, with a 30 day share price return of 20.67% and year to date share price return of 26.83%, alongside a 1 year total shareholder return of 57.07% and 5 year total...

H. Lundbeck (CPSE:HLUN B) has wrapped up FY 2025 with fourth quarter revenue of DKK6.1b and basic EPS of DKK0.03 loss, alongside trailing twelve month EPS of DKK3.22 on revenue of DKK24.6b. Over the past year, the company has seen quarterly revenue move from DKK5.5b in Q4 2024 to between DKK6.0b and DKK6.3b across 2025, while quarterly EPS ranged from DKK0.60 in Q4 2024 to between DKK0.97 and DKK1.16 in the first three quarters of 2025 before the small loss in Q4. With margins tightening over...

Pandora A/S has released its fourth-quarter and full-year 2025 results, reporting quarterly sales of DKK 11,859 million and full-year sales of DKK 32,549 million, with earnings per share edging higher despite broadly stable net income. Alongside detailing 6% organic growth for 2025, Pandora outlined 2026 guidance, plans to reduce commodity exposure, and proposed a higher dividend with future share buybacks, underlining management’s current priorities for profitable expansion and capital...

ChemoMetec (CPSE:CHEMM) opened H1 2026 with total revenue of DKK 244.1 million, basic EPS of DKK 4.77 and net income of DKK 83.1 million, setting the tone for another closely watched update. The company has seen revenue move from DKK 208.1 million in H2 2024 to DKK 251.5 million in H1 2025 and DKK 244.1 million in H2 2025, while basic EPS over those periods shifted from DKK 3.78 to DKK 5.94 and then DKK 4.77. This gives investors a clear view of how the top and bottom lines have tracked...

Rockwool (CPSE:ROCK B) has wrapped up FY 2025 with fourth quarter revenue of €989 million and a net loss of €332 million, setting a stark contrast against earlier quarters where earnings were positive. Over the year, revenue has sat in a relatively tight range between €959 million and €989 million per quarter, while basic EPS moved from €0.54 in Q1 2025 to €0.6 in both Q2 and Q3 before the swing into loss in Q4, and trailing twelve month net income shifted from €550 million in Q4 2024 to €28...

Q1 2026 earnings snapshot and context Ambu (CPSE:AMBU B) opened its 2026 financial year with Q1 revenue of DKK 1,558 million and basic EPS of DKK 0.44, framing the latest update against a period where earnings growth and margin changes have already been in focus for investors. Over the last twelve months, the company has seen revenue move from DKK 5,391 million to DKK 6,085 million on a trailing basis, while trailing basic EPS shifted from DKK 0.88 to DKK 2.04, giving you a clearer view of...

Ringkjøbing Landbobank FY 2025 results in focus Ringkjøbing Landbobank (CPSE:RILBA) has wrapped up FY 2025 with Q4 total revenue of DKK 1,042.9 million and basic EPS of DKK 22.87, while trailing twelve month revenue came in at DKK 4.16 billion and EPS at DKK 92.86. The bank has seen quarterly revenue move between DKK 1,020.1 million in Q4 2024 and DKK 1,073.5 million in Q1 2025, with basic EPS ranging from DKK 20.68 in Q4 2024 to DKK 23.87 in Q3 2025. On a trailing view, non performing loans...

Wondering whether Carlsberg’s current share price really reflects what you are getting as an investor? This article walks through the numbers so you can judge the value for yourself. Carlsberg’s shares last closed at DKK 939.0, with returns of 10.2% over 7 days, 13.5% over 30 days, 13.7% year to date, 22.2% over 1 year, 5.9% over 3 years and 11.7% over 5 years. This provides useful context before thinking about what the stock might be worth. Recent coverage around Carlsberg has focused on...

DSV (CPSE:DSV) is in focus after reporting full year 2025 earnings that were broadly in line with guidance, alongside fresh 2026 EBIT guidance that factors in meaningful Schenker integration synergies. See our latest analysis for DSV. Alongside the 2025 earnings and fresh 2026 EBIT guidance, DSV’s share price has been strong, with a 30 day share price return of 13.42% and a 90 day gain of 31.65%. The 1 year total shareholder return of 31.15% and 5 year total shareholder return of 84.99% point...

Demant (CPSE:DEMANT) has reported FY 2025 second half revenue of DKK 11.7b with EPS of DKK 5.87, while trailing twelve month revenue stands at DKK 23.0b and EPS at DKK 11.21, setting the stage for a results season where profits and sales are both firmly in focus. The company has seen revenue move from DKK 11.3b in the second half of 2024 to DKK 11.7b in the second half of 2025, with half year EPS shifting from DKK 7.15 to DKK 5.87 and trailing twelve month EPS moving from DKK 13.31 to DKK...

Novo Nordisk (CPSE:NOVO B) has closed out FY 2025 with fourth quarter revenue of DKK 79.1 billion and basic EPS of DKK 6.05, against trailing twelve month revenue of DKK 309.1 billion and EPS of DKK 23.06. Over recent periods, the company has seen quarterly revenue range from DKK 74.9 billion to DKK 85.7 billion, with basic EPS moving between DKK 4.50 and DKK 6.54. This sets the backdrop for investors focused on how margins and earnings sustainability shape the story from here. See our full...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...